|
|
 |
 |
| Latest news from Equity |
|
| Jaiprakash Hydro to raise upto $314 m Utility Jaiprakash Hydropwer Ltd said on Saturday its board had approved raising up to Rs 1500 crore ($314 million) through the sale of shares, depositary receipts or bonds.More India Infoline ties up with global e-broker Infoline has tied up with Interactive Brokers LLC, an automated global electronic broker, to provide its clients online access to trade in overseas securities. More Ashok Leyland June sales down 44% year-on-year Ashok Leyland's sales have doubled in June when compared with that of its sales in May. However, June sales this year is 44 per cent down over that in June 2008. More HUL to rationalise costs, prices Waging a war on costs is Hindustan Unilever's agenda in times of an economic downturn. Speaking at the company's 76th AGM, Harish Manwani, Chairman, HUL, said, "It will be business as usual onMore SBI's consolidation proposal hits union hurdle The Centre has advised the State Bank of India not to pursue with the Reserve Bank of India the issue of acquisition of State Bank of Indore. Instead, the Government has now asked the SBIMore RNRL moves apex court to make Reliance execute order Reliance Natural Resources Ltd (RNRL) of the Anil Ambani group has filed a Special Leave Petition in the Supreme Court on Friday. More IndusInd Bank doubles dividend to 12% for FY09 Private sector IndusInd Bank approved a dividend of 12 per cent for FY 09 as against 6 per cent for the previous year. More UCO Bank plans foray into non-life insurance: CMD State-run UCO Bank is planning a foray into non-life insurance by floating a joint venture company by September, its top official said on Friday. More Govt to recall 4 govt directors from Satyam board Four of the six government nominated directors will be withdrawn from the board of Indian outsourcer Mahindra Satyam Ltd, the chairman of India's Company Law Board (CLB) said on Friday. More Orchid Chemicals gets US FDA nod for BP tablets Orchid Chemicals & Pharmaceuticals on Thursday said it has received approval from the US drug regulator for its anti-hypertensive tablets. More |
|
| © Copyright Sify Ltd, 1998-2006. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre. Site optimized for Internet Explorer 5.5 and above. See Disclaimer | Privacy Policy & Parental Guidance on pornography | careers@sify | About Us | Feedback | Advertise |
